corporate_fare
Instituto De Salud Carlos III
- Address
- Pab 6 Sotano, Avenida Monforte De Lemos 5
Sponsor Overview
assignment
1
sponsored trial
science
1
molecule
location_city
1
research centre
public
1
country
person_search
1
investigator
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase II Randomized, Double‑Blind, Placebo‑Controlled Study of Dasatinib to Reduce HIV‑1 Reservoir, Chronic Inflammation and Immune Senescence in ART‑suppressed Adults |  Spain | Not Yet Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Virus Diseases1 trial182 other sponsors
Partnered Research Centres
1 centrelocation_city
assignment579Hospital Clinico San Carlos
- Address
- Calle Del Profesor Martin Lagos Sn, 28040 Madrid
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Instituto De Salud Carlos III.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.